Neurosurgical Robotics Market Report 2025

The neurosurgical robotics market size has grown rapidly in recent years. It will grow from $3.62 billion in 2024 to $4.14 billion in 2025 at a compound annual growth rate (CAGR) of 14.6%. The growth during the historical period can be attributed to the rising demand for minimally invasive surgeries, the increasing prevalence of neurological disorders, a growing global aging population, the expansion of the neurosurgeon workforce and training programs, and higher healthcare spending in developed countries.

The neurosurgical robotics market size is expected to see rapid growth in the next few years. It will grow to $7.05 billion in 2029 at a compound annual growth rate (CAGR) of 14.2%. The growth during the forecast period can be attributed to the increasing demand for precision in complex neurosurgical procedures, the expanding availability of reimbursement policies, the development of healthcare infrastructure in emerging economies, growing awareness of the benefits of robotic surgery, and the rise in partnerships between med-tech companies and hospitals. Key trends in this period include technological advancements in neurosurgical navigation, ongoing innovation in robotic arms and instruments, increased investment in research and development, improvements in real-time imaging, and the broader integration of cloud-based data solutions in surgical systems.

The growing demand for minimally invasive surgical procedures is expected to drive the expansion of the neurosurgical robotics market in the coming years. Minimally invasive surgery involves techniques that reduce the size and number of incisions, minimizing trauma to the body during operations. This rising demand is fueled by faster patient recovery, as these procedures cause less physical trauma, resulting in shorter hospital stays, reduced pain, and a quicker return to normal activities. Neurosurgical robotics facilitates minimally invasive procedures by improving surgical precision, stability, and control, enabling surgeons to perform operations through smaller incisions with greater accuracy and a lower risk of complications. For example, in June 2024, the American Society of Plastic Surgeons, a US-based organization of board-certified plastic surgeons, reported a 7% increase in minimally invasive procedures in 2023, with the total surpassing 25 million. Consequently, the growing popularity of minimally invasive surgeries is propelling the neurosurgical robotics market forward.

Leading companies in the neurosurgical robotics sector are concentrating on developing advanced solutions, such as robotic exoscope systems, to improve surgical precision, visualization, and minimally invasive capabilities in complex cranial and spinal operations. A robotic exoscope system is an advanced surgical visualization tool that integrates a high-resolution external scope (exoscope) with robotic-assisted controls, providing enhanced hands-free imaging during surgery. For instance, in September 2024, Zeiss Medical Technology, a Germany-based medical technology provider, introduced the Kinevo 900 S robotic visualization system for neurosurgery procedures. The ZEISS KINEVO 900 S offers features that significantly improve neurosurgical precision and workflow. It combines high-resolution 4K 3D hybrid visualization, allowing surgeons to switch seamlessly between optical and digital views for greater comfort and accuracy. The system also includes advanced cobotic functionalities such as PointLock, PositionMemory, and AutoCenter, which enable hands-free, AI-assisted positioning of the surgical view. Its DepthPro mode enhances the depth of field with a single click, keeping more of the surgical field in sharp focus.

In March 2025, BenQ Medical Technology Corporation, a Taiwan-based medical device provider, partnered with Brain Navi Biotechnology Co. Ltd. to expand access to AI-powered robotic neurosurgical systems and promote intelligent medical solutions globally. This partnership aims to integrate Brain Navi’s advanced neurosurgical navigation technologies with BenQ Medical’s global distribution and manufacturing capabilities, accelerating the worldwide adoption of robotic-assisted cranial surgeries. Brain Navi Biotechnology Co. Ltd., based in Taiwan, specializes in surgical navigation robots used in neurosurgical procedures.

Major players in the neurosurgical robotics market are Medtronic Plc, Stryker Corporation, Zimmer Biomet Holdings Inc., Renishaw Plc, Brainlab AG, Panda Surgical Limited, Monteris Medical Inc., Synaptive Medical Inc., Novarad Corporation, Myomo Inc., ClearPoint Neuro Inc., ZAP Surgical Systems Inc., Robeauté SAS, Galen Robotics Limited, Axilum Robotics SA, AiM Medical Robotics Inc., NaoTrac, Zeta Surgical Inc., Brain Navi Biotechnology Co. Ltd., and Artedrone SAS.

North America was the largest region in the neurosurgical robotics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in neurosurgical robotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the neurosurgical robotics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

Neurosurgical robotics refers to the use of advanced robotic systems in neurological surgical procedures to enhance precision, control, and outcomes. These systems combine high-resolution imaging, advanced navigation technologies, and robotic arms with fine motor control to assist surgeons in performing delicate brain and spine operations.

The primary types of neurosurgical robotics include precision robotic systems, navigation systems, and surgical assist systems. Precision robotic systems are advanced robotic technologies designed to perform highly accurate and minimally invasive surgical tasks, particularly in complex and delicate procedures such as neurosurgery. They are used in various surgery types, including minimally invasive and open procedures, and are applied in brain tumor resection, deep brain stimulation (DBS), and spine surgery. They serve multiple end users, including hospitals and ambulatory surgical centers.

The neurosurgical robotics market research report is one of a series of new reports that provides neurosurgical robotics market statistics, including neurosurgical robotics industry global market size, regional shares, competitors with a neurosurgical robotics market share, neurosurgical robotics market segments, market trends and opportunities, and any further data you may need to thrive in the neurosurgical robotics industry. This neurosurgical robotics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The neurosurgical robotics market consists of revenues earned by entities by providing services such as preoperative surgical planning support, real-time motion tracking, cranial surgery robotics support, and robotic system maintenance. The market value includes the value of related goods sold by the service provider or included within the service offering. The neurosurgical robotics market also includes sales of robotic-assisted surgical systems, neuro navigation systems, stereotactic systems, and endoscopic robotic systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.